7 terminated. 7 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Terminated 7 |
| Phase 1 | 2 | Terminated 2 |
| Phase 3 | 1 | Terminated 1 |
Follow PTSD: new trials by email Literature Review of PTSD trials Research Report on PTSD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ultrasonic Neuromodulation for Treatment of PTSD Diadem - PTSD | Phase 1 / Phase 2 | Terminated | University of Utah | 10 | 2024-04-05 | 2025-05-25 |
| Safety and Efficacy of 50 mg NYX-783 QD vs. Placebo in PTSD NYX-783, Placebo - PTSD | Phase 2 / Phase 3 | Terminated | Aptinyx | 121 | 2021-12-13 | 2023-04-07 |
| Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD Midomafetamine, Psychotherapy - PTSD | Phase 2 | Terminated | Resilient Pharmaceuticals | 26 | 2021-11-08 | 2025-07-15 |
| Nitrous Oxide for PTSD Nitrous Oxide, Midazolam, Nitrogen - PTSD | Phase 2 | Terminated | VA Office of Research and Development | 1 | 2021-10-07 | 2023-03-03 |
| SKY vs. HEP in PTSD Sudarshan Kriya Yoga, Health Enhancement Program - PTSD | Phase 2 | Terminated | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 49 | 2018-08-01 | 2022-06-01 |
| Proof-of-concept Study to Assess the Efficacy and Safety of SRX246 in Adults With PTSD SRX246, Placebo - PTSD | Phase 2 | Terminated | Azevan Pharmaceuticals | 33 | 2016-12-01 | 2021-11-01 |
| Reducing Risk and Trauma-Related Stress in Persons Living With HIV HIV Skills-based Prevention - HIV, PTSD | Phase 1 / Phase 2 | Terminated | Stanford University | 102 | 2003-04-01 | 2006-10-06 |
Stress Disorders, Post-Traumatic (7) · Acquired Immunodeficiency Syndrome (1)
Mental Disorders (7) · Stress Disorders, Traumatic (7) · Trauma and Stressor Related Disorders (7) · Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · HIV Infections (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Infections (1) · Lentivirus Infections (1) · RNA Virus Infections (1) · Retroviridae Infections (1) · Sexually Transmitted Diseases (1) · Sexually Transmitted Diseases, Viral (1)
Midazolam (1) · N-Methyl-3,4-methylenedioxyamphetamine (1) · Nitrogen (1) · Nitrous Oxide (1) · Oxygen (1) · Psychotherapy (1) · SRX246 (1) · Sodium Chloride (1)
Aptinyx (1) · Azevan Pharmaceuticals (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Resilient Pharmaceuticals (1) · Stanford University (1) · University of Utah (1) · VA Office of Research and Development (1)
United States (6) · Canada (1)
Carolyn I Rodriguez, MD PhD (1) · Cheryl Gore-Felton, PhD (1) · Elisabeth Wilde, PhD (1) · Jan Kubanek, PhD (1) · Rachel Yehuda (1)
I01CX001789 (1)